Literature DB >> 22100316

Sex-specific risk factors for recurrent venous thromboembolism.

Valérie Olié1, Tienan Zhu, Isabelle Martinez, Pierre-Yves Scarabin, Joseph Emmerich.   

Abstract

BACKGROUND: Men have higher risk of recurrent venous thromboembolism (VTE) than women but this sex difference remains unexplained. In addition, whether men and women share same risk factors for recurrent VTE is unclear.
METHODS: In a prospective cohort study, 583 patients (234 men and 349 women) aged 18 to 90, with a first idiopathic VTE, were followed for an average of 28 months. We assessed the association between baseline characteristics and VTE recurrence by gender.
RESULTS: Recurrent VTE occurred in 38 women and 36 men (incidence=4.6% and 7.5% per year respectively; HR=1.6; 95% CI, 1.0-2.6). This relation between sex and recurrent VTE was more pronounced in patients younger than 50 years and in the presence of factor V Leiden (FVL) mutation. Multivariate analyses showed that obesity (HR, 2.8 (95% CI, 1.3-6.0)) and aging (HR, 1.3 (95% CI, 1.1-1.4) per 10 years increase) were related to an increased risk of recurrent VTE in women while FVL mutation (HR, 3.5 (95% CI, 1.5-8.1)) was a risk factor of recurrent VTE among men.
CONCLUSION: Men and women do not share the same risk factors for recurrent VTE. Consequently, gender has to be taken into account to improve the risk stratification and prevention of VTE recurrence.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22100316     DOI: 10.1016/j.thromres.2011.10.026

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  9 in total

Review 1.  Predicting the risk of recurrent venous thromboembolism (VTE).

Authors:  Michael B Streiff
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

2.  Polymorphisms in PARK2 and MRPL37 are associated with higher risk of recurrent venous thromboembolism in a sex-specific manner.

Authors:  Kristina Sundquist; Abrar Ahmad; Peter J Svensson; Bengt Zöller; Jan Sundquist; Ashfaque A Memon
Journal:  J Thromb Thrombolysis       Date:  2018-08       Impact factor: 2.300

3.  Incidence of venous thromboembolism in France: a retrospective analysis of a national insurance claims database.

Authors:  Stéphane Bouée; Corinne Emery; Adeline Samson; Julie Gourmelen; Cécile Bailly; François-Emery Cotté
Journal:  Thromb J       Date:  2016-02-19

4.  Risk indicators for venous thrombosis in first-degree relatives of patients with recurrent venous thromboembolism in Chinese.

Authors:  Lianxing Zhao; Chunsheng Li; Rui Shao; Yingying Fang
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

5.  Obesity is not associated with recurrent venous thromboembolism in elderly patients: Results from the prospective SWITCO65+ cohort study.

Authors:  Carolin Mueller; Andreas Limacher; Marie Méan; Nicolas Rodondi; Drahomir Aujesky
Journal:  PLoS One       Date:  2017-09-15       Impact factor: 3.240

6.  Incidence and Risk Factors of Recurrent Venous Thromboembolism after Pulmonary Embolism.

Authors:  Hun Gyu Hwang; Won Il Choi; Bora Lee; Choong Won Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2019-05-31

7.  Association between obesity and venous thromboembolism.

Authors:  Cristina Hotoleanu
Journal:  Med Pharm Rep       Date:  2020-04-22

8.  Current Knowledge on Factor V Leiden Mutation as a Risk Factor for Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis.

Authors:  Daria Eppenberger; Henning Nilius; Betsy Anagnostelis; Carola A Huber; Michael Nagler
Journal:  Front Cardiovasc Med       Date:  2022-04-07

Review 9.  Gene-environment interactions in severe intraventricular hemorrhage of preterm neonates.

Authors:  Laura R Ment; Ulrika Adén; Aiping Lin; Soo Hyun Kwon; Murim Choi; Mikko Hallman; Richard P Lifton; Heping Zhang; Charles R Bauer
Journal:  Pediatr Res       Date:  2013-11-05       Impact factor: 3.756

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.